Sodium Sulfacetamide
NDC Package 0168-0484-01
Package Information
Sodium Sulfacetamide is a medication used as a skin cleansing product to treat dandruff and other skin conditions (e.g., seborrheic dermatitis). Marketed by E. Fougera & Co., A Division Of Nycomed Us Inc., this product is identified by NDC 0168-0484.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0168 - E. Fougera & Co., A Division Of Nycomed Us Inc.
- 0168-0484 - Sodium Sulfacetamide
- 0168-0484-01 - 30 POUCH in 1 CARTON / 1 APPLICATOR in 1 POUCH / 1 g in 1 APPLICATOR
- 0168-0484 - Sodium Sulfacetamide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0168-0484-01 identifies a specific commercial package of 30 pouch in 1 carton / 1 applicator in 1 pouch / 1 g in 1 applicator of Sodium Sulfacetamide, labeled by E. Fougera & Co., A Division Of Nycomed Us Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by E. Fougera & Co., A Division Of Nycomed Us Inc. on March 12, 2010. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
This medication is used as a skin cleansing product to treat dandruff and other skin conditions (e.g., seborrheic dermatitis). It is also used to treat certain bacterial skin infections. Sulfacetamide is a sulfonamide antibiotic. It works by stopping the growth of bacteria.
How is this E. Fougera & Co., A Division Of Nycomed Us Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00168048401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.